GO:0051126 negative regulation of actin nucleation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051126 (negative regulation of actin nucleation) describes any process that stops, prevents, or reduces the frequency, rate, or extent of actin nucleation, the initial step of actin filament formation.
• Key negative regulators include JMY, which is inhibited by TTC5/STRAP and LC3 during autophagy, and whose actin nucleation activity suppresses neuritogenesis.
• Calcium ions attenuate the nucleation activity of leiomodin, providing a direct biochemical switch for negative regulation.
• The actin nucleator Diaph3 is negatively regulated by Stub1-mediated degradation, forming a feedback loop.
• Pathogens such as Yersinia and Staphylococcus manipulate actin nucleation through effectors like YopO and cortactin to subvert host cytoskeletal dynamics [6,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of nucleation regulators in disease and development [1,3,5].
Description
Actin nucleation is the rate-limiting initial step in the formation of actin filaments, in which actin monomers combine to form a new filament. The Gene Ontology term GO:0051126, negative regulation of actin nucleation, encompasses any process that stops, prevents, or reduces the frequency, rate, or extent of this nucleation event. This regulation is critical for maintaining cytoskeletal architecture, cell motility, and membrane trafficking, and its dysregulation is linked to developmental defects and disease [3,5]. Researchers study this term to understand how cells temporally and spatially control actin assembly, and to identify therapeutic targets in cancer, neurodegeneration, and infectious disease [6,8]. The QuickGO definition provides a precise scope: it includes inhibition of actin nucleation by proteins such as JMY, leiomodin, and Diaph3, as well as pathogen-derived effectors that hijack host nucleation machinery [1,2,5,6].
negative regulation of actin nucleation At A Glance
| GO ID | GO:0051126 |
|---|---|
| GO term | negative regulation of actin nucleation |
| Ontology | biological_process |
| Synonym | down regulation of actin nucleation, down-regulation of actin nucleation, downregulation of actin nucleation, inhibition of actin nucleation |
| Major function | Reduces the frequency, rate, or extent of actin nucleation, the initial step of actin filament formation |
| Key regulators | JMY, leiomodin, Diaph3, TTC5/STRAP, LC3, Stub1, APC, EB1 |
| Pathogen effectors | YopO (Yersinia), cortactin-targeting effectors from Gram-positive and Gram-negative bacteria |
| Disease relevance | Neuritogenesis defects, cancer cell migration, bacterial pathogenesis |
What Is GO:0051126?
Negative regulation of actin nucleation (GO:0051126) is a biological process that decreases the initiation of new actin filaments. It acts on the step where actin monomers first associate into a stable nucleus, thereby reducing the number of filaments formed. This regulation can occur through direct inhibition of nucleation-promoting factors, sequestration of monomers, or targeted degradation of nucleators [1,2,5].
Why Is negative regulation of actin nucleation Important in Cell Biology?
Negative regulation of actin nucleation is essential for cellular homeostasis because uncontrolled actin polymerization drives aberrant cell migration, invasion, and morphological changes seen in cancer and developmental disorders [3,5]. It also plays a central role in host-pathogen interactions, as bacterial effectors such as YopO and cortactin-targeting proteins manipulate actin nucleation to promote infection [6,8]. Understanding this process provides mechanistic insights into autophagy, neuritogenesis, and immune signaling, and offers targets for therapeutic intervention [1,3,6].
• Controls the timing and location of actin filament formation, preventing spontaneous polymerization.
• Regulates neuritogenesis through JMY, whose nucleation activity is a negative regulator of neurite outgrowth.
• Calcium signaling attenuates leiomodin nucleation activity, linking ionic signals to cytoskeletal remodeling.
• Stub1-mediated degradation of Diaph3 provides a negative feedback loop to limit actin nucleation.
• Bacterial pathogens like Yersinia inject YopO to manipulate actin nucleation and evade phagocytosis.
• Cortactin is a common target of bacterial effectors that subvert host actin dynamics.
• Dysregulation contributes to cancer metastasis and invasion.
• Autophagy-related proteins TTC5/STRAP and LC3 regulate JMY nucleation activity.
• EB1 and APC coordinate microtubule and actin nucleation for cell polarity.
• Pan1p in yeast links endocytosis to actin nucleation regulation.
What Happens During negative regulation of actin nucleation?
Inhibition of nucleation-promoting factors
In simple terms: Proteins that start actin filament formation are blocked or turned off.
Negative regulation often targets nucleation-promoting factors (NPFs) such as JMY and Diaph3. JMY's actin nucleation activity is inhibited by TTC5/STRAP and LC3 during autophagy, preventing excessive actin assembly under stress conditions. Similarly, the activated form of Diaph3 is degraded by Stub1, providing a negative feedback mechanism that limits nucleation.
Calcium-dependent attenuation
In simple terms: Calcium ions can directly reduce the ability of some nucleators to start filaments.
Leiomodin, an actin nucleator, has its nucleation activity attenuated by calcium ions. This provides a rapid, reversible switch to downregulate actin nucleation in response to calcium signaling.
Sequestration and degradation of nucleators
In simple terms: Nucleators are removed or destroyed so they cannot start new filaments.
Stub1 promotes the degradation of activated Diaph3, a formin-family nucleator, thereby reducing actin nucleation. This ubiquitin-proteasome pathway ensures that nucleation is tightly controlled and not sustained indefinitely.
Pathogen-mediated subversion
In simple terms: Bacteria inject proteins that interfere with the host's actin nucleation machinery.
Pathogens such as Yersinia and Staphylococcus manipulate actin nucleation through effectors like YopO and cortactin-targeting proteins. YopO interacts with actin and inhibits nucleation, while cortactin is a universal target of bacterial effectors that alter host cytoskeletal dynamics [6,8].
Coordination with microtubule networks
In simple terms: Actin nucleation is regulated in concert with microtubules to control cell polarity.
EB1 directly regulates APC-mediated actin nucleation, linking microtubule plus-end tracking to actin assembly. This coordination ensures that negative regulation of actin nucleation is spatially and temporally integrated with cell polarity cues.
Key Genes Involved in GO:0051126 negative regulation of actin nucleation
The following genes and proteins are experimentally validated participants in negative regulation of actin nucleation (GO:0051126).
| Gene | Major Role | Research Relevance |
|---|---|---|
| JMY | Actin nucleation factor; inhibited by TTC5/STRAP and LC3 | Autophagy, neuritogenesis [1,3] |
| TTC5/STRAP | Inhibits JMY nucleation activity during autophagy | Autophagy regulation |
| LC3 | Inhibits JMY nucleation activity during autophagy | Autophagy |
| Leiomodin | Nucleation activity attenuated by Ca2+ | Calcium signaling, actin dynamics |
| Diaph3 | Formin nucleator; degraded by Stub1 | Feedback regulation, cytokinesis |
| Stub1 | E3 ubiquitin ligase promoting Diaph3 degradation | Protein quality control |
| APC | Regulates actin nucleation; modulated by EB1 | Cell polarity, migration |
| EB1 | Directly regulates APC-mediated actin nucleation | Microtubule-actin crosstalk |
| Cortactin | Host cytoskeletal target of bacterial effectors | Host-pathogen interactions |
| YopO | Yersinia effector that inhibits actin nucleation | Bacterial pathogenesis |
| Pan1p | Yeast actin director of endocytosis | Endocytosis, yeast genetics |
| Pyrin | Inflammasome sensor linked to actin regulation | Host-microbe interactions |
| Arp2/3 complex | Actin nucleator targeted by negative regulators | Cytoskeletal dynamics [1,5] |
| Formins | Nucleators regulated by degradation and calcium | Actin assembly [2,5] |
| WASP | Nucleation-promoting factor regulated by pathogens | Immune evasion |
| VASP | Actin regulator targeted by bacterial effectors | Pathogen manipulation |
| Profilin | Actin monomer-binding protein affecting nucleation | Actin turnover |
How Is negative regulation of actin nucleation Regulated?
Negative regulation of actin nucleation is controlled at multiple levels. JMY is inhibited by TTC5/STRAP and LC3 during autophagy, linking nucleation to autophagic stress. Calcium ions directly attenuate leiomodin nucleation activity. Stub1-mediated ubiquitination and degradation of Diaph3 provides a negative feedback loop. Additionally, EB1 regulates APC-mediated nucleation, integrating microtubule dynamics with actin assembly. Pathogen effectors such as YopO and cortactin-targeting proteins can also modulate this process during infection [6,8].
negative regulation of actin nucleation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JMY | Neuritogenesis defects, autophagy dysregulation | JMY knockout neurons, overexpression [1,3] |
| Diaph3 | Cancer metastasis, cytokinesis failure | Stub1 knockout, Diaph3 point mutant |
| Leiomodin | Cardiomyopathy, calcium signaling defects | Leiomodin knock-in with Ca2+ binding mutation |
| Cortactin | Bacterial infection susceptibility | Cortactin knockout cells infected with pathogens |
| APC | Colorectal cancer, cell polarity defects | APC knockout, EB1 knock-in |
Cancer and metastasis
Dysregulated actin nucleation contributes to cancer cell migration and invasion. Negative regulators such as Diaph3, when degraded by Stub1, can lead to increased nucleation and metastatic potential. Targeting these feedback mechanisms may offer therapeutic strategies.
Neurodegeneration and neuritogenesis
JMY is a negative regulator of neuritogenesis; its nucleation activity must be tightly controlled for proper neuronal development. Disruption of JMY regulation may contribute to neurodevelopmental disorders.
Infectious disease
Bacterial pathogens like Yersinia and Staphylococcus manipulate host actin nucleation through effectors such as YopO and cortactin-targeting proteins, promoting infection and immune evasion [6,8].
Autophagy-related disorders
The inhibition of JMY by TTC5/STRAP and LC3 links actin nucleation regulation to autophagy. Defects in this pathway may impair autophagic flux and contribute to diseases such as neurodegeneration and cancer.
From negative regulation of actin nucleation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of JMY increase actin nucleation? | JMY knockout cell line [1,3] |
| How does Ca2+ binding affect leiomodin nucleation? | Leiomodin point mutant (Ca2+ binding site) |
| What is the effect of Stub1-mediated Diaph3 degradation? | Stub1 knockout or Diaph3 phospho-mutant |
| How does EB1 regulate APC nucleation? | EB1 tagged knock-in for live imaging |
| Can overexpression of TTC5/STRAP inhibit JMY? | TTC5/STRAP overexpression |
| Does YopO inhibit actin nucleation in host cells? | YopO overexpression or infection model |
How to Study the negative regulation of actin nucleation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Pyrene-actin polymerization | Actin nucleation and elongation rates | In vitro testing of inhibitors |
| Live-cell microscopy | Real-time actin dynamics | JMY, Diaph3 localization [1,3] |
| Co-immunoprecipitation | Protein-protein interactions | TTC5/STRAP-JMY binding |
| Ubiquitination assays | Degradation of nucleators | Stub1-Diaph3 regulation |
| CRISPR knockout screens | Gene function in nucleation | Identify negative regulators |
| RNA-seq | Transcriptional changes | Pathogen infection models |
| Proteomics | Protein abundance and modifications | Stub1 targets |
| FRET biosensors | Nucleation activity in live cells | Calcium effects on leiomodin |
Live-cell imaging of actin nucleation
Fluorescently labeled actin or nucleation reporters (e.g., GFP-JMY) allow real-time visualization of nucleation events and the effect of negative regulators [1,3].
Biochemical nucleation assays
Pyrene-actin polymerization assays measure the rate of nucleation in vitro, and can be used to test the inhibitory effects of proteins like leiomodin or Stub1 [2,5].
Proteomics and interactomics
Mass spectrometry can identify proteins that interact with nucleation factors and mediate their negative regulation, such as TTC5/STRAP and LC3 with JMY.
CRISPR-based genetic screens
Genome-wide knockout screens can uncover novel negative regulators of actin nucleation by selecting for altered cytoskeletal phenotypes [5,8].
How CRISPR Can Be Used to Study GO:0051126 negative regulation of actin nucleation
Knockout
CRISPR knockout of negative regulators such as JMY or Stub1 can lead to increased actin nucleation, revealing their inhibitory roles. For example, JMY knockout enhances neuritogenesis, confirming its negative regulatory function.
Point Mutation
Point mutations in calcium-binding sites of leiomodin can abolish calcium-dependent attenuation of nucleation, helping dissect the molecular switch.
Knock-in
Tagged knock-in of EB1 or APC allows live-cell imaging of their dynamic regulation of actin nucleation.
Overexpression
Overexpression of TTC5/STRAP or LC3 can inhibit JMY nucleation activity, providing a gain-of-function approach to study negative regulation.
How EDITGENE Supports negative regulation of actin nucleation Research
Researchers studying negative regulation of actin nucleation-related genes often need to determine whether a candidate gene is causally involved in controlling actin filament formation, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of actin nucleation research.
Frequently Asked Questions About negative regulation of actin nucleation
What is negative regulation of actin nucleation?
It is a biological process (GO:0051126) that stops, prevents, or reduces the frequency, rate, or extent of actin nucleation, the initial step of actin filament formation.
What genes are involved in negative regulation of actin nucleation?
Key genes include JMY, TTC5/STRAP, LC3, leiomodin, Diaph3, Stub1, APC, EB1, and cortactin [1,2,4,5,8].
How is actin nucleation negatively regulated during autophagy?
During autophagy, TTC5/STRAP and LC3 inhibit JMY's actin nucleation activity, preventing excessive actin assembly.
What role does calcium play in negative regulation of actin nucleation?
Calcium ions attenuate the nucleation activity of leiomodin, providing a direct biochemical switch.
How do bacteria manipulate actin nucleation?
Pathogens like Yersinia inject YopO, which inhibits actin nucleation, and other bacteria target cortactin to subvert host cytoskeletal dynamics [6,8].
What is the relationship between JMY and neuritogenesis?
JMY is a negative regulator of neuritogenesis; its actin nucleation activity suppresses neurite outgrowth.
How does Stub1 regulate Diaph3?
Stub1 promotes the degradation of activated Diaph3, providing a negative feedback mechanism to limit actin nucleation.
What experimental models are used to study negative regulation of actin nucleation?
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as in vitro actin polymerization assays [1,2,4,5].
Why is negative regulation of actin nucleation important in cancer?
Dysregulation can lead to increased cell migration and invasion; targeting negative regulators may reduce metastasis.
What methods are used to measure actin nucleation?
Pyrene-actin polymerization, live-cell imaging, co-immunoprecipitation, and CRISPR screens [1,2,5].
Conclusion
Negative regulation of actin nucleation (GO:0051126) is a critical process that controls the initiation of actin filaments, impacting cell motility, development, and disease. Key regulators such as JMY, leiomodin, and Diaph3 are subject to inhibition by TTC5/STRAP, LC3, calcium, and Stub1, while pathogens like Yersinia manipulate this process for infection [1,2,5,6]. Understanding these mechanisms offers insights into cancer, neurodegeneration, and infectious diseases. EDITGENE provides advanced CRISPR tools to dissect these pathways and accelerate therapeutic discovery.
References
- 1. Liu X et al.. 2019. Regulation of JMY's actin nucleation activity by TTC5/STRAP and LC3 during autophagy.. Autophagy 15(3):373-374 PMID: 30593260
- 2. Smith GE et al.. 2022. Ca(2+) attenuates nucleation activity of leiomodin.. Protein Sci 31(7):e4358 PMID: 35762710
- 3. Firat-Karalar EN et al.. 2011. The actin nucleation factor JMY is a negative regulator of neuritogenesis.. Mol Biol Cell 22(23):4563-74 PMID: 21965285
- 4. Juanes MA et al.. 2020. EB1 Directly Regulates APC-Mediated Actin Nucleation.. Curr Biol 30(23):4763-4772.e8 PMID: 33007249
- 5. Qiu C et al.. 2024. Stub1 promotes degradation of the activated Diaph3: A negative feedback regulatory mechanism of the actin nucleator.. J Biol Chem 300(10):107813 PMID: 39322015
- 6. Loeven NA et al.. 2020. The pyrin inflammasome in host-microbe interactions.. Curr Opin Microbiol 54:77-86 PMID: 32120337
- 7. Huang B et al.. 2007. Pan1p: an actin director of endocytosis in yeast.. Int J Biochem Cell Biol 39(10):1760-4 PMID: 17303466
- 8. Sharafutdinov I et al.. 2022. Cortactin: A universal host cytoskeletal target of Gram-negative and Gram-positive bacterial pathogens.. Mol Microbiol 118(6):623-636 PMID: 36396951
